Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specified Drug Use-Results Survey of EVRENZO® Tablets: Non-interventional, Prospective Drug Use-results Survey in the Realworld Use of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia

NCT04408820 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT04408820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04408820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specified Drug Use-Results Survey of EVRENZO® Tablets: Non-interventional, Prospective Drug Use-results Survey in the Realworld Use of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia
Lead sponsor
Astellas Pharma Inc
Phase
Observational
Overall status
Completed
Start date
June 1, 2020
Completion date
June 23, 2025
Enrollment
2,104 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

renal anemia